Celerion | Phoenix Celerion CPU

Research site

Location

2420 W Baseline Road, Tempe, Arizona, United States of America

Website

http://www.celerion.com

Site insights

Top conditions

Top treatments

Itraconazole

Selpercatinib

Rifampin

LY3527723

Donepezil

Midazolam

TAK-279

Omeprazole

MGL-3196

Lansoprazole

Parent organization

This site is a part of Celerion

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Active trials

11 of 180 total trials

Status recently updated

A Cardiac Liability Study of Varegacestat in Healthy Participants

This clinical study is designed to study the effect of a single dose of varegacestat on cardiac repolarization in healthy adult participants.

Begins enrollment in 1 month

Enrolling

Healthy Volunteer

Drug: Moxifloxacin 400 mg

Drug: Placebo

A Drug-Drug Interaction Study of Carbamazepine and Opevesostat (MK-5684) in Healthy Adult Male Participants (MK-5684-012)

Researchers have designed a study medicine called opevesostat as a new way to treat prostate cancer.The purpose of this study is to learn what happen...

Active, not recruiting

Healthy

Drug: Carbamazepine

Drug: Opevesostat

A First-In-Human Study of TAK-004 in Healthy Adults

This study is the first study with TAK-004 conducted in human beings. Participants will receive either TAK-004 or placebo. The main aim of this study...

Enrolling

Healthy Volunteers

Drug: Placebo

Drug: TAK-004

A Phase 1 Study to Examine the Effects of Itraconazole After Single Dose Administration of Varegacestat (AL102) to Healthy Participants

This is an open label, fixed sequence, 1-way crossover drug-drug interaction (DDI) study in healthy participants.

Active, not recruiting

Healthy Volunteer

Drug: Itraconazole (200 mg)

Drug: varegacestat

A Phase I Study of CDX-622

This is a study to determine the safety of CDX-622 in healthy participants.

Enrolling

Healthy Participants

Drug: Normal Saline

Drug: CDX-622

A Single and Multiple Ascending Dose Study of CK-4021586 in Healthy Adult Participants

The purposes of this study are to:* Learn about the safety and tolerability of CK 4021586 after a single dose and multiple doses in healthy subjects....

Enrolling

Healthy Participants

Drug: CK-4021586

Drug: Placebo for CK-4021586

A Study of Interaction of Zasocitinib (TAK-279) With Other Medicines in Healthy Adults

The main aim of this study is to find out how zasocitinib (TAK-279) interacts with other medicines taken by mouth (orally). This will be examined by...

Enrolling

Healthy Volunteers

Drug: Esomeprazole

Drug: Digoxin

A Study to Evaluate a Single-Dose Subcutaneous Axatilimab Compared With Intravenous Axatilimab in Healthy Participants

This study will be conducted to evaluate a Single-Dose Subcutaneous (SC) Axatilimab Compared With Intravenous Axatilimab in Healthy Participants.

Enrolling

Healthy Participants

Drug: Axatilimab

Drug-Drug Interaction Study of Bomedemstat and Carbamazepine in Healthy Adult Participants (MK-3543-020)

Researchers have designed a study medicine called bomedemstat (MK-3543) as a new way to treat certain rare blood diseases.The purpose of this study i...

Active, not recruiting

Healthy

Drug: bomedemstat

Drug: carbamazepine

Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study of PORT-77 Administered to Healthy Adult Participants

A First-in-Human 2-part, randomized, double-blind, placebo-controlled, single ascending dose, multiple ascending dose, and food effect, investigation...

Enrolling

Healthy Adult Participants

Drug: Placebo

Drug: PORT-77

Study to Evaluate Safety and Activity of TRL345 in Healthy Volunteers

This study in healthy volunteers will provide a basis for evaluation of TRL345 as a first in human study, specifically, important safety, tolerabilit...

Active, not recruiting

Healthy Volunteers

Drug: TRL345, a human monoclonal antibody